Ultrasensitive Liquid Biopsy Tech Spots Cancer Earlier than Standard Methods
Researchers developed an AI-based method for detecting tumor DNA in blood with high sensitivity, improving prediction of cancer recurrence.
Read MorePosted by Andy Lundin | Jun 14, 2024 | Cancer |
Researchers developed an AI-based method for detecting tumor DNA in blood with high sensitivity, improving prediction of cancer recurrence.
Read MorePosted by Andy Lundin | Jun 13, 2024 | Miscellaneous |
Researchers discovered that honeybees can detect biomarkers associated with lung cancer in human breath, potentially leading to new tests.
Read MorePosted by Andy Lundin | Jun 7, 2024 | Lung Cancer |
Researchers have developed an AI-powered liquid biopsy to identify lung cancer earlier through DNA fragment patterns in blood.
Read MorePosted by Andy Lundin | Jun 3, 2024 | Lung Cancer |
DELFI’s blood-based Lung test has been clinically validated to enhance early detection of lung cancer, demonstrating high sensitivity.
Read MorePosted by Chris Wolski | May 31, 2024 | Immunoassay Reagents & test Kits |
Personalis, Inc. has partnered with Tempus to commercialize NeXT Personal, an ultra-sensitive, whole genome-based liquid biopsy assay.
Read More